Maurice is a fierce champion of innovation and works at the intersection of life sciences and early commercialization. As Program Director, Life Sciences at Start2 Group, Maurice leads multiple funding programs supporting the development of therapeutics on behalf of the BARDA Accelerator Network Hub, VITAL.

Before that, Maurice spent five years with Start2 running the German Accelerator Life Sciences Market Access program. Through this program, Maurice was responsible for helping startups across the healthtech and life sciences spectrum identify, understand, and address the commercial risks and unique complexities of the U.S. market.

Prior to his role at Start2, Maurice worked as an independent consultant in operations for several small and emerging biotech companies. Before that, Maurice was a medicinal chemist for 9+ years in the discovery and development of small molecule therapeutics for infectious diseases (anti-infectives, anti-malarials) and cancer (immuno-oncology) at the Broad Institute of MIT and Harvard and Ensemble Therapeutics.

Maurice holds a B.S. in Biology from Trinity College (Hartford, CT), a Ph.D. in Chemistry from Emory University (Atlanta, GA), and an MBA in Health Sector Management from Boston University (Boston, MA).